TLR4 and Hyperammonemia: The observation that treatment with a TLR4 antagonist reduces circulating ammonia to levels seen with ammonia scavengers in clinically relevant models of hyperammonemia provides the rationale for proof-of-concept clinical studies with TLR4 antagonists.